Today, March 23, 2020, the International Journal of Laboratory Hematology released a study describing the clinical efficacy attributes of PTT-based one-stage clotting assays and two-stage chromogenic assays for the extended half-life factor IX concentrate, Alprolix. Click or tap the citation for the open-access article. Thank you to Dr. Ali Sadeghi-Khomami, Precision BioLogic Inc. for the heads-up.
Sommer JM, Sadeghi-Khomami A, Barnowski C, Wikén M, Willemze AJ. Real-world assay variability between laboratories in monitoring of recombinant factor IX Fc fusion protein activity in plasma samples. Int J Lab Hematol 2020. DOI: 10.1111/ijlh.13189.
No comments here.